NIAID Funding News, September 19, 2018

September 19, 2018 NIAID Funding News Read this full issue online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  Comment on Draft Updates to NIH's Clinical Trial Protocol Template The Behavioral and Social Sciences Clinical Trials Template will inform an update to the Clinical e-Protocol Writing Tool, which applicants can use as a guide when preparing comprehensive clinical protocols for Phase 2 and 3 clinical trials. Opportunities and Resources Take Requisite Steps Now for Clinical Center FOA To apply for the Expanding Extramural Research Opportunities at the NIH Clinical Center funding opportunity announcement, you'll first need to obtain a letter from the Clinical Center director to confirm that the Clinical Center facilities will be able to accommodate your proposed research. New Way To Apply for Academic Research Enhancement Award NIAID will support Academic Research Enhancement Awards focused on undergraduate institutions or academic components in which the undergraduate student enrollment is greater than the graduate student enrollment. Reissued Opportunity for Supplements: Improve Research Workforce Diversity NIAID will help current grantees recruit and support students, postdocs, and other eligible investigators from diverse backgrounds to work on research experiences integral to a grant's ongoing research, with the potential to contribute significantly to the career development of the candidates. In The News Stay Abreast of Important NIH and NIAID Resources Check out a list of five new resources, which includes helpful information on informed consent, intellectual property security, and early-stage investigator status, to ensure you're following the latest guidance on these topics. Comment on Proposed Changes to Human Gene Therapy Trials Proposed changes to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules would 1) remove the NIH protocol submission, review, and reporting requirements under Appendix M of the NIH Guidelines and 2) modify the roles and responsibilities of the Recombinant DNA Advisory Committee. Advice Corner A Correction for Delayed Onset Applications You will not select "Add New Study" and complete Section 3 - Protection and Monitoring Plans in a grant application for a delayed onset study. Reader Questions "Must a hospital have a negotiated F&A rate agreement with a federal agency to be a subawardee on an NIH grant?" "Can I pursue F32-sponsored postdoctoral training at a foreign institution?" New Funding Opportunities PA-18-926, Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp) PAR-18-923, Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) RFP-NIAID-DAIDS-NIHAI201800006, Patient Safety Monitoring In International Laboratories (SMILE) See other announcements at Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Thursday, September 20, 2018 — Add Comment